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Introduction: Accurate prediction of outcome after emergency surgery in elderly patients may assist
decision-making. Many scoring systems require post-operative data (e.g. P-POSSUM) whilst others have
failed to gain widespread use. Recent reports suggest that C-reactive protein (CRP) and the neutrophil
lymphocyte (N/L ratio) ratio may predict surgical outcome.
Methods: A retrospective review of all patients aged 80 years or over undergoing emergency abdominal
surgery over a 22 month period was conducted. Outcome and clinical data were collected. Univariate,
multivariate and recursive analyses were performed for outcome at 30 days, 6 months and 12 months.
Findings were validated in a second independent dataset.
Results: 88 patients were included in the test dataset, median age 84 years. 30-day mortality was 31%, 6-
month mortality 43% and 12-month mortality 50%. Univariate analysis identiﬁed N/L ratio, CRP, midline
laparotomy, and surgical risk score to predict outcome at each time point. Recursive analysis showed, N/L
ratio 22 best predicted 30-day outcome (p¼ 0.0018). Multivariate analysis identiﬁed N/L ratio to be an
independent predictor of 30-day outcome (p¼ 0.004) yet CRP did not predict outcome at any time point.
An independent dataset (n¼ 84) conﬁrmed N/L ratio to be a prognostic factor at 30 days (p¼ 0.001), 6
months (p< 0.001) and 12 months (p¼ 0.001).
Conclusion: N/L ratio is an easily calculable pre-operative measure that may have utility in the prediction
of outcome after emergency abdominal surgery in the elderly. Further work to validate this measure in
a larger, prospective setting and determine the underlying mechanisms that mediate outcome are
necessary.
 2012 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Introduction
An increasing proportion of our population is over 65 years old
and forms a large proportion of hospital admissions. The diagnosis
and treatment of the elderly brings challenges of providing the
highest quality care and maximising quality of life, independence
and dignity with the minimum of risk. Many studies have argued
that chronological age alone is a poor predictor of outcome after
surgery,1e4 and co-morbidities are of much greater signiﬁcance.3,5,6
However, a higher risk is associated with emergency surgery in the
elderly,6e11 and as risk increases the decision to operate becomes
increasingly difﬁcult. A number of scoring systems have been
developed but are not widely used. APACHE II was devised asng).
ript.
Elsevier Ltd on behalf of Surgicala general measure of severity of disease in intensive care admis-
sions yet does not consider surgical diagnosis and evidence for its
role in predicting surgical risk is limited.12,13 POSSUM and P-POS-
SUM14e16 are highly validated surgical scoring systems developed
for comparative surgical audit but require operative severity data
which limits their pre-operative use and their validity in an
elderly population is debated.17e20 The Surgical Risk Scale21
(Supplementary Table 1) combines the Conﬁdential Enquiry into
Peri-operative Death (CEPOD) rating of the procedure, the British
United Provident Association (BUPA) classiﬁcation of the operative
severity and the American Society of Anaesthesiologists (ASA) score
of ﬁtness for surgery. This score considers both patient condition
and magnitude of surgery and is calculated using clinical data that
are available for every patient. Although developed for use in
comparative surgical audit it has been shown to have some utility
in pre-operative risk prediction in both elective and emergency
settings but has failed to gain widespread use.22,23
The disadvantages of current outcome prediction scores have
led some investigators to assess the utility of novel predictors ofAssociates Ltd.
Table 1
Table showing patient demographics and mean ASA, CEPOD, BUPA and SRS scores
together with 30-day, 6-month and 12-month survival for test and validation
datasets.
Test dataset
(n¼ 88)
Validation
dataset (n¼ 84)
p Value
Sex Male 45 Male 34 0.2116
Female 43 Female 50
Median age (range) 84 (80 e 95) 84 (80e94) 0.92
Median stay in days (range) 15 (0e72) 17 (0e94) 0.15
Mean CEPOD score (95% CI) 2.94 (2.86e3.03) 3.06 (3.01e3.11) 0.1952
Mean ASA score (95% CI) 2.84 (2.65e3.03) 3.54 (3.41e3.68) < 0.0001
Mean BUPA score (95% CI) 3.43 (3.29e3.58) 3.82 (3.73e3.92) <0.0001
Mean SRS score (95% CI) 9.22 (8.93e9.50) 10.43(10.26e10.60) <0.0001
Mean N/L ratio (95% CI) 12.1 (9.99e14.21) 14.5 (11.34e17.74) 0.47
30 Day mortality (%) 27 (31) 18 (21) 0.13
6 Month mortality (%) 38 (43) 30 (36) 0.40
12 Month mortality (%) 44 (50) 35 (42) 0.23
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lymphocyte ratio (N/L ratio). The use of CRP in predicting post-
operative course may relate to its use as a marker of inﬂamma-
tion and the relationship between pre-operative inﬂammation and
post-operative course,24,25 yet there remains little evidence for its
role in the risk stratiﬁcation of general surgical patients. More
recently the neutrophil/lymphocyte ratio (neutrophil count divided
by lymphocyte count, N/L ratio) has been suggested as potentially
useful yet few studies have considered the role of neutrophil/
lymphocyte ratio in predicting peri-operative outcome. It is sug-
gested that neutrophil/lymphocyte ratio, acting as a surrogate
maker of inﬂammatory response to liver metastases, predicts both
overall and disease-free survival,26 whilst N/L ratio also predicts the
severity of clinical course in both medical and post-operative
surgical patients in an intensive care unit.27 The aim of this study
is to identify useful predictors of surgical outcome in elderly
patients over the age of 80.
2. Methods
2.1. Data collection
Patients aged 80 years or over undergoing emergency abdominal surgery from
May 2005 to February 2007 at a single centre were identiﬁed retrospectively from
electronic hospital coding systems (Test Dataset). Included were patients under-
going emergency abdominal surgery, appendicectomy, inguinal and femoral hernia
repairs. Data were collected on presenting complaint, co-morbidities, routine
laboratory investigations including full blood count and C-reactive protein (latest
pre-operative results); diagnosis; operative ﬁndings and operation performed; post-
operative complications, length of intensive care stay, total hospital stay and 30-day
mortality. ASA scores were obtained from the anaesthetic records. BUPA and CEPOD
categories were classiﬁed independently from the available data by two authors
(PVS and JR) and any disparity in the scoring resolved after discussion. The cate-
gories to which each patient was allocated were converted into a numerical value
using the scoring system described by Sutton et al.21
A second cohort (Validation Dataset) of all patients aged 80 years or over
undergoing emergency abdominal surgery at a second centre (university teaching
hospital) from October 2008 to April 2010 was also identiﬁed retrospectively.
Patients were identiﬁed from electronic theatre records and data collected from
electronic patient records.
2.2. Statistical analysis
Data were collated in Excel (Microsoft Inc., Seattle, USA) and analysed using
Microsoft Excel, Prism 3.03 (GraphPad Software Inc., La Jolla, USA) and SPSS 18.0
(SPSS Inc., Chicago USA). Descriptive statistics were produced using Excel and
PRISM. Univariate survival analysis was undertaken using the KaplaneMeier
approach and signiﬁcant differences identiﬁed using the log-rank test. A recursive
approach was undertaken to identify the values of N/L ratio that predicted outcome
and a K-means cluster analysis performed to conﬁrm the most signiﬁcant cut-off for
N/L ratio. Univariate analysis between the groups ‘survived’ and ‘died’ at 3 endpoints
was performed to identify signiﬁcant variables (log-rank c2 test). Variables entered
into this model included demographic data, co-morbidity data, laboratory results
and ASA, BUPA, CEPOD and SRS scores. Variables with potential to predict outcome
(p< 0.1) at any temporal endpoint on univariate analysis were included in a multi-
variate survival model using a Cox regression (stepwise forward model) approach.
Variables includedwere age, malignancy, laparotomy, CEPOD score, BUPA score, ASA
score, SRS score, previous TIA, Chronic kidney disease, last pre-operative white cell
count, haemoglobin count, neutrophil count, CRP and N/L ratio. N/L lymphocyte
ratio was plotted against death rate using a linear regression approach to provide
a clinically useful tool for the prediction of outcome. This estimated the death rate at
each time point for a given N/L and goodness of ﬁt values (R2) for the model were
calculated for 30-day, 6 month and 12 month survival data.
3. Results
3.1. Patient demographics
The test dataset included 88 patients. Demographics and
hospital stay are shown in Table 1. The commonest pre-operative
diagnosis was small bowel obstruction and 19 patients had an
underlying malignancy. Pre-operative diagnoses and co-
morbidities are shown in Supplementary Tables 2 and 3.Themean ASA scorewas 2.84, with a narrow conﬁdence interval
suggesting a consistently high degree of co-morbidity pre-opera-
tively (95% CI 2.65e3.03). CEPOD scoring reﬂected the emergency
nature of the patients with a mean score of 2.94 (95% CI 2.86e3.03),
whilst the BUPA operative severity score indicated that themajority
of individuals underwent a signiﬁcant operative intervention
(Score 3.43 (95% CI 3.29e3.58); Table 1). The average N/L ratio was
12.1 (range 2.02e58.5; 95% CI 9.99e14.21). The 30-day mortality
was 31% (n¼ 27), 6-month mortality 43% (n¼ 38) and 12-month
mortality 50% (n¼ 44).
The validation dataset included 84 patients with amedian age of
84 years and mean ASA score¼ 3.54 (95% CI 3.41e3.68). 30-day
mortality was 21% (n¼ 18), 6-month mortality was 36% (n¼ 30)
and 12-month mortality 42% (n¼ 35).3.2. Univariate survival analysis using previously validated
classiﬁcation tools and patient co-morbidity
Survival was differentiated in the test cohort by ASA score,
CEPOD classiﬁcation and SRS at 30 days, six and twelve months but
not by BUPA score (Table 1). Univariate analysis of individual co-
morbidities (Supplementary Table 3) revealed that transient
ischaemic attack (TIA) and chronic kidney disease (CKD) differen-
tiated outcome (p< 0.1) (Table 2).3.3. Identiﬁcation of predictors of outcome in study group and
veriﬁcation of utility of scoring systems
Midline laparotomy was a signiﬁcant predictor of outcome at all
endpoints (p< 0.01), whilst the presence of malignancy did not
affect short-term outcome, but did predict survival at 12 months
(p¼ 0.02; Tables 2aec). Variables with predictive signiﬁcance of
p< 0.1 were included in the multivariate analysis. This model
identiﬁed N/L ratio as an independent prognostic factor at 30 days
(p¼ 0.004, df¼ 1, c2¼ 8.144) but not at 6 or 12 months. CEPOD
predicted outcome at 6 months (p¼ 0.001, df¼ 2, c2¼ 9.16) and 12
months (p¼ 0.001, df¼ 2, c2¼15.04) whilst ASA predicted 12
month outcome alone (p< 0.0001, df¼ 8, c2¼ 43.49). CRP did not
predict outcome at any endpoint in this model. Midline laparotomy
(when compared to other abdominal incisions) was also an inde-
pendent predictor of outcome at 30 days (p¼ 0.001, df¼ 2,
c2¼15.071), 6 months (p< 0.001, df¼ 3, c2¼ 21.874), and 12
months (p< 0.001, df¼ 3, c2¼ 23.805).
Table 2a
Factors affecting 30-day mortality in test dataset.
Died 30 days Survived >30 days Univariate odds
ratio (95% CI)
p Value Multivariate odds
ratio (95% CI)
p Value
n 29 59 e
Male gender 13 (45%) 30 (51%) 1.23 (0.59e2.56) 0.57 e e
Mean age (95% CI) 85.65 (83.1e85.1) 84.07 (84.3e87.0) 1.07 (0.99e1.16) 0.10 NS 0.11
Malignancy 8 (28%) 11 (19%) 1.35 (0.60e3.05) 0.47 NS 0.21
Previous TIA 5 (17%) 4 (7%) 2.30 (0.88e6.04) 0.08 NS 0.92
Chronic kidney disease 3 (10%) 0 (0%) 4.65 (1.37e15.7) 0.06 NS 0.30
Midline laparotomy 28 (97%) 40 (68%) 10.0 (1.36e73.51) 0.005 8.86 (1.20e65.46) 0.001
Appendicectomy 1 (3%) 4 (7%) 0.58 (0.08e4.26) 0.59 e e
Groin/ventral hernia repair 0 14 (24%) 0.04 (0.001e1.94) 0.009 NS 0.11
Mean CEPOD score (95% CI) 3.10 (3.0e3.3) 2.86 (2.8e3.0) 4.02 (1.61e10.07) 0.006 NS 0.21
Mean ASA score
(95% CI) 3.14 (2.8e3.5) 2.69 (2.5e2.9) 1.72 (1.10e2.69) 0.02 NS 0.39
Mean BUPA score
(95% CI) 3.62 (3.4e3.9) 3.34 (3.2e3.5) 1.64 (0.99e2.74) 0.06 NS 0.81
Mean SRS score (95% CI) 9.86 (9.4e10.4) 8.90 (8.6e9.2) 1.56 (1.21e2.02) 0.001 NS 0.51
Mean CRP (95% CI) 109.99 (77.3e142.7) 67.67 (43.2e92.2) 1.00 (1.00e1.01) 0.05 NS 0.14
Mean haemoglobin (95% CI) 11.65 (10.8e12.5) 12.69 (12.0e13.4) 0.87 (0.75e1.01) 0.08 NS 0.36
Mean WCC (95% CI) 13.06 (10.9e15.2) 10.70 (9.6e11.9) 1.08 (1.01e1.16) 0.32 NS 0.16
Mean neutrophil count (95% CI) 11.10 (9.0e13.2) 8.81 (7.7e9.9) 1.09 (1.01e1.17) 0.025 NS 0.15
Mean lymphocyte count (95% CI) 0.97 (0.7e1.2) 1.10 (1.0e1.2) 0.67 (0.33e1.38) 0.27 e e
Mean N/L ratio (95% CI) 16.40 (11.7e21.1) 10.02 (8.1e12.0) 1.04 (1.01e1.07) 0.002 1.03 (1.01e1.06) 0.004
P.G. Vaughan-Shaw et al. / International Journal of Surgery 10 (2012) 157e162 159
ORIGINAL RESEARCH3.4. Survival and recursive analyses of predictors of outcome
Using a recursive approach, an N/L ratio of 22 most signiﬁ-
cantly differentiated survival in the cohort (c2¼ 9.784, df¼ 1,
p¼ 0.0018; Fig. 1) at 30 days (Supplementary Table 4). A k-means
cluster analysis (k¼ 2) was subsequently performed and revealed
the most signiﬁcant N/L ratio cut-off to be 22.85.
3.5. Derivation of a model for prediction of outcome
A clinically useful tool for the prediction of outcome modelled
N/L lymphocyte ratio against death rate using a linear regression
approach (Fig. 2). The model derived had goodness of ﬁt values (R2)
of 0.87 for the 30-day survival data, 0.835 for 6 month survival data
and 0.692 for the 12 month survival data.
3.6. Validation of model using independent dataset (validation
dataset)
Comparison between the test and validation datasets is shown
in Table 1. There were no differences in age, N/L ratio, 30-day,Table 2b
Factors affecting 6-month mortality in test dataset.
Died 6 months Survived >6 months Univ
n 38 50
Male gender 18 (47%) 25 (50%) 1.10
Mean age (95% CI) 85.37 (84.3e86.5) 84.00 (82.8e85.2) 1.06
Malignancy 11 (29%) 8 (16%) 1.52
Previous TIA 6 (16%) 3 (6%) 2.22
Chronic kidney disease 3 (8%) 0 4.65
Midline laparotomy 35 (92%) 33 (66%) 4.47
Appendicectomy 1 (3%) 4 (8%) 0.41
Groin/ventral hernia repair 2 (5%) 12 (24%) 0.22
Mean CEPOD score (95% CI) 2.84 (2.7e2.9) 3.08 (2.9e3.2) 4.11
Mean ASA score (95% CI) 2.68 (2.5e2.9) 3.05 (2.8e3.4) 1.56
Mean BUPA score (95% CI) 3.34 (3.2e3.5) 3.55 (3.3e3.8) 1.46
Mean SRS score (95% CI) 8.86 (8.5e9.2) 9.68 (9.2e10.2) 1.48
Mean CRP (95% CI) 91.69 (63.6e119.8) 74.79 (46.8e102.8) 1.00
Mean haemoglobin (95% CI) 11.92 (11.1e12.8) 12.68 (12.1e13.3) 0.90
Mean WCC (95% CI) 12.31 (10.68e14.0) 10.85 (9.5e12.2) 1.05
Mean neutrophil count (95% CI) 10.32 (8.7e12.0) 8.99 (7.8e10.2) 1.06
Mean lymphocyte count (95% CI) 1.06 (0.9e1.3) 1.06 (0.9e1.2) 0.90
Mean N/L ratio (95% CI) 14.01 (10.1e17.9) 10.69 (8.5e12.9) 1.036-month and 12-month mortality but ASA grade, BUPA score and
SRS score were higher in test dataset (p< 0.0001).
The N/L ratio cut-off of 22.85 derived from the test dataset was
applied to the validation dataset using a univariate approach and
predicted outcome at 30 days (p¼ 0.0053), 6 months (p¼ 0.0099)
and 12 months (p¼ 0.0336; Fig. 3). Multivariate analysis of the
validation dataset including the same variables as the test dataset
using a forward stepwise Cox regression also showed N/L ratio to be
an independent prognostic factor (p¼ 0.001, df¼ 2, c2¼15.071) at
30 days, six months (p< 0.001, df¼ 1, c2¼12.536) and 12 months
(p¼ 0.001, df¼ 1, c2¼10.27). No other variable independently
predicted outcome in this dataset at all three time points.
3.7. Utility analysis and validation of N/L ratio in the validation
dataset
Having identiﬁed that N/L ratio had prognostic utility when
predicting outcome in elderly patients undergoing emergency
abdominal surgery we further studied its potential clinical utility
through the assessment of predictive accuracy and compared N/L
22.85 against survival at 30 days, 6 months and 12 months in theariate odds ratio (95%CI) p value Multivariate odds ratio (95%CI) p value
e e e
(0.58e2.09) 0.76 e e
(0.98e1.14) 0.124 NS 0.15
(0.75e3.06) 0.24 NS 0.08
(0.93e5.31) 0.07 NS 0.83
(1.37e15.70) 0.06 NS 0.67
(1.37e14.54) 0.006 5.84 (1.39e24.53) <0.0001
2 (0.06e3.01) 0.37 NS 0.29
(0.05e0.92) 0.02 NS 0.45
(1.75e9.64) 0.003 N/A 0.001
(1.06e2.30) 0.03 NS 0.053
(0.93e2.30) 0.10 NS 0.97
(1.17e1.86) 0.001 NS 0.90
(1.00e1.01) 0.27 NS 0.12
(0.79e1.03) 0.13 NS 0.53
(0.99e1.12) 0.11 NS 0.08
(0.99e1.13) 0.11 NS 0.06
(0.50e1.60) 0.71 e e
(1.00e1.06) 0.034 NS 0.31
Table 2c
Factors affecting 12-month mortality in test dataset.
Died 12 months Survived >12 months Univariate odds ratio (95%CI) p value Multivariate odds ratio (95%CI) p value
n 44 44 e e e e
Male gender 22 (50%) 21 (48%) 0.97 (0.54e1.76) 0.93 e e
Mean age (95% CI) 85.71 (84.6e86.0) 83.48 (82.4e84.6) 1.08 (1.02e1.15) 0.01 1.09 (1.02e1.17) <0.0001
Malignancy 15 (34%) 4 (9%) 2.06 (1.10e3.86) 0.02 2.62 (1.25e5.49) <0.0001
Previous TIA 6 (14%) 3 (7%) 1.97 (0.83e4.67) 0.12 NS 0.17
Chronic kidney disease 3 (7%) 0 4.65 (1.38e15.68) 0.006 NS 0.47
Midline laparotomy 40 (91%) 28 (64%) 4.01 (1.43e11.24) 0.004 5.06 (1.17e21.85) <0.0001
Appendicectomy 2 (5%) 3 (7%) 0.70 (0.17e2.88) 0.62 NS 0.18
Groin/ventral hernia repair 2 (5%) 12 (27%) 0.18 (0.5e0.76) 0.009 NS 0.57
Mean CEPOD score (95% CI) 3.02 (2.9e3.2) 2.86 (2.8e3.0) 2.96 (1.25e7.01) 0.02 N/A 0.001
Mean ASA score (95% CI) 3.00 (2.7e3.3) 2.68 (2.4e2.9) 1.48 (1.03e2.13) 0.03 NS 0.47
Mean BUPA score (95% CI) 3.52 (3.3e3.7) 3.34 (3.2e3.5) 1.39 (0.91e2.14) 0.13 NS 0.87
Mean SRS score (95% CI) 9.55 (9.1e10.0) 8.89 (8.5e9.3) 1.41 (1.12e1.76) 0.003 NS 0.68
Mean CRP (95% CI) 94.03 (67.1e121.0) 70.85 (41.6e100.1) 1.00 (1.00e1.01) 0.19 NS 0.61
Mean haemoglobin (95% CI) 11.98 (11.2e12.8) 12.72 (12.0e13.4) 0.91 (0.81e1.03) 0.13 NS 0.81
Mean WCC (95% CI) 12.53 (11.0e14.1) 10.43 (9.1e11.8) 1.06 (1.00e1.13) 0.04 NS 0.87
Mean neutrophil count (95% CI) 10.50 (9.0e12.0) 8.62 (7.3e9.9) 1.07 (1.00e1.14) 0.04 1.09 (1.01e1.16) <0.0001
Mean lymphocyte count (95% CI) 1.09 (0.9e1.3) 1.03 (0.8e1.2) 1.00 (0.60e1.68) 0.99 e e
Mean N/L ratio (95% CI) 13.56 (10.1e17.0) 10.69 (8.3e13.1) 1.03 (1.00e1.05) 0.04 NS 0.72
NS Non-signiﬁcant.
N/A overall odds ratio not available for categorical variables.
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calculated and shown to be moderately high at 30 days (88%), 6
months (89%) and 12 months (88%) (Table 3). Negative predictive
value at 30 days was 84% (95%CI 74e91) and positive predictive
value 47% (95%CI 25e70). N/L ratio has a good overall accuracy in
the early period after surgery (30 days; 77%) but became increas-
ingly inaccurate at 6 months (68%) and 12 months (62%).
4. Discussion
Accurate prediction of outcome after emergency surgery,
particularly in the elderly, would be advantageous, assisting clini-
cians when discussing early morbidity and mortality with patients
and their families and guiding difﬁcult treatment decisions. TheFig. 1. KaplaneMeier survival curves for ASA scores and N/L ratio need for improvedmethods to predict short-term clinical outcomes
in these patients is highlighted by the 50% 12 month mortality in
the recruited patients.
Many outcome prediction models have been suggested
although none speciﬁc to the elderly patient.28 Furthermore certain
scoring tools require operative information e.g. POSSUM15 and
therefore cannot be easily used in the pre-operative period. In our
test dataset both ASA and CEPOD scoring predicted mortality sug-
gesting that data from our cohort, even considering individual
patient variation, were generalisable in terms of outcome. CRP,
however, was not an independent predictor of outcome.
Three recent reports suggest that N/L ratio may predict outcome
after resection of colorectal carcinoma,29 colorectal liver metas-
tases,26 and in critically unwell individuals in an intensive care22 in test dataset, p values calculated using log-rank approach.
Fig. 2. Graph describing death rate against N/L ratio in test dataset with line of best ﬁt
plotted.
Table 3
Sensitivity and speciﬁcity of neutrophil/lymphocyte (N/L) ratio 22.85 and lapa-
rotomy in validation dataset.
N/L ratio 22.85 30 Day mortality 6 Month mortality 12 Month mortality
Sensitivity 39% (95%CI 18e64) 30% (95%CI 15e50) 26% (95%CI 13e44)
Speciﬁcity 88% (95%CI 77e94) 89% (95%CI 77e95) 88% (95%CI 75e95)
Laparotomy
Sensitivity 94% (95%CI 71e100) 93% (95%CI 76e99) 89% (95%CI 72e96)
Speciﬁcity 14% (95%CI 7e25) 15% (95%CI 7e28) 12% (95%CI 5e25)
N/L ratio ‡22.85 and laparotomy
Sensitivity 39% (95%CI 18e64) 30% (95%CI 26e47) 26% (95%CI 13e44)
Speciﬁcity 89% (95%CI 79e95) 91% (95%CI 79e97) 90% (95%CI 77e96)
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of outcome on multivariate analysis (p¼ 0.004, df¼ 1, c2¼ 8.144)
suggesting potential clinical utility. A recursive approach showed
that an N/L ratio of22.85 best differentiated survival in the cohortFig. 3. KaplaneMeier survival curves for N/L ratio 22.85 in test dataset, p values
calculated using log-rank approach.at 30 days, 6 months and 12 months. This cut-off was validated
using a K-means approach to overcome the limitations of recursive
analysis. To validate the utility of N/L ratio in this setting we
undertook the analysis in a second independent cohort (Validation
Dataset) which conﬁrmed N/L ratio to be an independent prog-
nostic marker at 30 days, but also at 6 months and 12 months.
To further investigate N/L ratio utility as a prognostic tool we
demonstrated that it had a moderately high speciﬁcity (88%) and
a high accuracy (77%) at 30 days. The negative predictive value was
84% showing that patients with a low ratio were likely to survive.
However, positive predictive value was only 47% indicating that
a high N/L ratio does not necessarily predict a poor outcome.
Lymphopaenia and neutrophilia were commonly present in
patients who did not survive in both datasets. Whilst surgeons
often look for neutrophilia when determining whether a patient
has severe sepsis they rarely examine the lymphocyte count.
Further work is required to understand why this cohort of severely
unwell elderly patients had lymphopaenia and how this contrib-
uted to their outcome. In addition, further investigation to deter-
mine whether lymphopaenia is a response to severe sepsis through
lymphocyte apoptosis,30 or whether lymphopaenia characterises
an elderly group with an impaired immune system are required.31
The role of N/L ratio in predicting outcome in those under 80 years
of age also requires investigation.
This study had a number of limitations. Data were collected
retrospectively introducing the potential for selection bias.
Secondly risk prediction and outcome from a holistic standpoint
together with assessment of patient-reported outcomes are
necessary. The ability to conduct activities of daily living may
indicate good pre-morbid condition, while post-operative
discharge to a fully dependent existence in a nursing home may
indicate a poor outcome not identiﬁed by traditional markers of
morbidity or mortality. Indeed, health related quality of life indi-
cators, such as physical functioning, have been demonstrated to
have prognostic utility in a meta-analysis of clinical trials.32 Holistic
factors should not be overlooked and must be considered in the
decision-making process and in discussions with patients and
relatives.
5. Conclusions
The study demonstrates a high level of mortality following
emergency abdominal surgery in the elderly while analysis
identiﬁes N/L ratio as an independent predictor of outcome in
this cohort. N/L ratio of <22.85 or 22.85 was most discrimina-
tory for survival. The value of this marker was validated in an
independent dataset and performs with good speciﬁcity and
accuracy. Prospective evaluation of these ﬁnding in a larger
cohort to assess its clinical effectiveness is necessary together
with further studies to determine the biological rationale for
these ﬁndings.
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